221 related articles for article (PubMed ID: 20406803)
1. An intrabody based on a llama single-domain antibody targeting the N-terminal alpha-helical multimerization domain of HIV-1 rev prevents viral production.
Vercruysse T; Pardon E; Vanstreels E; Steyaert J; Daelemans D
J Biol Chem; 2010 Jul; 285(28):21768-80. PubMed ID: 20406803
[TBL] [Abstract][Full Text] [Related]
2. A stably expressed llama single-domain intrabody targeting Rev displays broad-spectrum anti-HIV activity.
Boons E; Li G; Vanstreels E; Vercruysse T; Pannecouque C; Vandamme AM; Daelemans D
Antiviral Res; 2014 Dec; 112():91-102. PubMed ID: 25453342
[TBL] [Abstract][Full Text] [Related]
3. Mapping the binding interface between an HIV-1 inhibiting intrabody and the viral protein Rev.
Vercruysse T; Boons E; Venken T; Vanstreels E; Voet A; Steyaert J; De Maeyer M; Daelemans D
PLoS One; 2013; 8(4):e60259. PubMed ID: 23565213
[TBL] [Abstract][Full Text] [Related]
4. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of the human immunodeficiency virus type 1 Rev protein oligomerization interface.
Thomas SL; Oft M; Jaksche H; Casari G; Heger P; Dobrovnik M; Bevec D; Hauber J
J Virol; 1998 Apr; 72(4):2935-44. PubMed ID: 9525614
[TBL] [Abstract][Full Text] [Related]
6. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
[TBL] [Abstract][Full Text] [Related]
7. Nucleocytoplasmic transport of the Rev protein of human immunodeficiency virus type 1 is dependent on the activation domain of the protein.
Wolff B; Cohen G; Hauber J; Meshcheryakova D; Rabeck C
Exp Cell Res; 1995 Mar; 217(1):31-41. PubMed ID: 7867718
[TBL] [Abstract][Full Text] [Related]
8. The carboxy-terminal region of the human immunodeficiency virus type 1 protein Rev has multiple roles in mediating CRM1-related Rev functions.
Hakata Y; Yamada M; Mabuchi N; Shida H
J Virol; 2002 Aug; 76(16):8079-89. PubMed ID: 12134013
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic analysis of human immunodeficiency virus type 1 Rev trimerization-interface mutants in human cells.
Trikha R; Brighty DW
J Gen Virol; 2005 May; 86(Pt 5):1509-1513. PubMed ID: 15831964
[TBL] [Abstract][Full Text] [Related]
10. Structural model for the cooperative assembly of HIV-1 Rev multimers on the RRE as deduced from analysis of assembly-defective mutants.
Jain C; Belasco JG
Mol Cell; 2001 Mar; 7(3):603-14. PubMed ID: 11463385
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs.
Yi R; Bogerd HP; Cullen BR
J Virol; 2002 Mar; 76(5):2036-42. PubMed ID: 11836381
[TBL] [Abstract][Full Text] [Related]
12. Solid-state NMR data support a helix-loop-helix structural model for the N-terminal half of HIV-1 Rev in fibrillar form.
Blanco FJ; Hess S; Pannell LK; Rizzo NW; Tycko R
J Mol Biol; 2001 Nov; 313(4):845-59. PubMed ID: 11697908
[TBL] [Abstract][Full Text] [Related]
13. Measuring cooperative Rev protein-protein interactions on Rev responsive RNA by fluorescence resonance energy transfer.
Vercruysse T; Pawar S; De Borggraeve W; Pardon E; Pavlakis GN; Pannecouque C; Steyaert J; Balzarini J; Daelemans D
RNA Biol; 2011; 8(2):316-24. PubMed ID: 21358282
[TBL] [Abstract][Full Text] [Related]
14. PRMT6 diminishes HIV-1 Rev binding to and export of viral RNA.
Invernizzi CF; Xie B; Richard S; Wainberg MA
Retrovirology; 2006 Dec; 3():93. PubMed ID: 17176473
[TBL] [Abstract][Full Text] [Related]
15. Nuclear Export Signal Masking Regulates HIV-1 Rev Trafficking and Viral RNA Nuclear Export.
Behrens RT; Aligeti M; Pocock GM; Higgins CA; Sherer NM
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852860
[TBL] [Abstract][Full Text] [Related]
16. Identification of a homogenous structural basis for oligomerization by retroviral Rev-like proteins.
Umunnakwe CN; Dorman KS; Dobbs D; Carpenter S
Retrovirology; 2017 Aug; 14(1):40. PubMed ID: 28830558
[TBL] [Abstract][Full Text] [Related]
17. Restriction of human immunodeficiency virus type 1 Rev function in murine A9 cells involves the Rev C-terminal domain.
Marques SM; Veyrune JL; Shukla RR; Kumar A
J Virol; 2003 Mar; 77(5):3084-90. PubMed ID: 12584334
[TBL] [Abstract][Full Text] [Related]
18. Computational modeling suggests dimerization of equine infectious anemia virus Rev is required for RNA binding.
Umunnakwe CN; Loyd H; Cornick K; Chavez JR; Dobbs D; Carpenter S
Retrovirology; 2014 Dec; 11():115. PubMed ID: 25533001
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy.
Lacourciere KA; Stivers JT; Marino JP
Biochemistry; 2000 May; 39(19):5630-41. PubMed ID: 10801313
[TBL] [Abstract][Full Text] [Related]
20. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
Nam YS; Petrovic A; Jeong KS; Venkatesan S
J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
